[1]
|
Sung, H., Ferlay, J., Siegel, R.L., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249.
https://doi.org/10.3322/caac.21660
|
[2]
|
Fu, Q. and Yu, Z. (2020) Phosphoglycerate Kinase 1 (PGK1) in Cancer: A Promising Target for Diagnosis and Therapy. Life Sciences, 256, Article ID: 117863. https://doi.org/10.1016/j.lfs.2020.117863
|
[3]
|
Fiorillo, A., Petrosino, M., Ilari, A., et al. (2018) The Phospho-glycerate Kinase 1 Variants Found in Carcinoma Cells Display Different Catalytic Activity and Conformational Stability Compared to the Native Enzyme. PLOS ONE, 13, e0199191. https://doi.org/10.1371/journal.pone.0199191
|
[4]
|
Danshina, P.V., Geyer, C.B., Dai, Q., et al. (2010) Phospho-glycerate Kinase 2 (PGK2) Is Essential for Sperm Function and Male Fertility in Mice. Biology of Reproduction, 82, 136-145. https://doi.org/10.1095/biolreprod.109.079699
|
[5]
|
Hu, H., Zhu, W., Qin, J., et al. (2017) Acetylation of PGK1 Promotes Liver Cancer Cell Proliferation and Tumorigenesis. Hepatology, 65, 515-528. https://doi.org/10.1002/hep.28887
|
[6]
|
Vas, M., Varga, A. and Gráczer, E. (2010) Insight into the Mechanism of Domain Movements and Their Role in Enzyme Function: Example of 3-Phosphoglycerate Kinase. Current Protein & Peptide Science, 11, 118-147.
https://doi.org/10.2174/138920310790848403
|
[7]
|
Sun, S., Liang, X., Zhang, X., Liu, T., Shi, Q., Song, Y., Jiang, Y., Wu, H., Jiang, Y., Lu, X. and Pang, D. (2015) Phosphoglycerate Kinase-1 Is a Predictor of Poor Survival and a Novel Prognostic Biomarker of Chemoresistance to Paclitaxel Treatment in Breast Cancer. British Journal of Cancer, 112, 1332-1339.
https://doi.org/10.1038/bjc.2015.114
|
[8]
|
Xu, D., Shao, F., Bian, X., Meng, Y., Liang, T. and Lu, Z. (2021) The Evolving Landscape of Noncanonical Functions of Metabolic Enzymes in Cancer and Other Pathologies. Cell Metabo-lism, 33, 33-50.
https://doi.org/10.1016/j.cmet.2020.12.015
|
[9]
|
Lu, Z. and Hunter, T. (2018) Metabolic Kinases Moonlighting as Protein Kinases. Trends in Biochemical Sciences, 43, 301-310. https://doi.org/10.1016/j.tibs.2018.01.006
|
[10]
|
Li, X., Zheng, Y. and Lu, Z. (2016) PGK1 Is a New Member of the Protein Kinome. Cell Cycle, 15, 1803-1804.
https://doi.org/10.1080/15384101.2016.1179037
|
[11]
|
Li, X., Jiang, Y., Meisenhelder, J., et al. (2016) Mitochon-dria-Translocated PGK1 Functions as a Protein Kinase to Coordinate Glycolysis and the TCA Cycle in Tumorigenesis. Molecular Cell, 61, 705-719.
https://doi.org/10.1016/j.molcel.2016.02.009
|
[12]
|
Qian, X., Li, X., Shi, Z., et al. (2019) PTEN Suppresses Glycol-ysis by Dephosphorylating and Inhibiting Autophosphorylated PGK1. Molecular Cell, 76, 516-527.e7. https://doi.org/10.1016/j.molcel.2019.08.006
|
[13]
|
Ahmad, S.S., Glatzle, J., Bajaeifer, K., et al. (2013) Phospho-glycerate Kinase 1 as a Promoter of Metastasis in Colon Cancer. International Journal of Oncology, 43, 586-590. https://doi.org/10.3892/ijo.2013.1971
|
[14]
|
Lowy, A.M., Clements, W.M., Bishop, J., et al. (2006) β-Catenin/Wnt Signaling Regulates Expression of the Membrane Type 3 Matrix Metalloproteinase in Gastric Cancer. Cancer Research, 66, 4734-4741.
https://doi.org/10.1158/0008-5472.CAN-05-4268
|
[15]
|
Li, X., Qian, X., Jiang, H., et al. (2018) Nuclear PGK1 Al-leviates ADP-Dependent Inhibition of CDC7 to Promote DNA Replication. Molecular Cell, 72, 650-660.e8. https://doi.org/10.1016/j.molcel.2018.09.007
|
[16]
|
李小龙. 人白细胞抗原分子B~*5801结构研究及磷酸甘油酸激酶与特拉唑嗪复合物结构研究[D]: [博士学位论文]. 合肥: 中国科学技术大学, 2016.
|
[17]
|
Tang, W., Wu, Y., Qi, X., et al. (2021) PGK1-Coupled HSP90 Stabilizes GSK3β Expression to Regulate the Stemness of Breast Cancer Stem Cells. Cancer Biology and Medicine, 19, 486-503.
https://doi.org/10.20892/j.issn.2095-3941.2020.0806
|
[18]
|
Katoh, M. and Katoh, M. (2009) Integrative Genomic Analyses of CXCR4: Transcriptional Regulation of CXCR4 Based on TGFβ, Nodal, Activin Signaling and POU5F1, FOXA2, FOXC2, FOXH1, SOX17, and GFI1 Transcription Factors. International Journal of Oncology, 36, 415-420. https://doi.org/10.3892/ijo_00000514
|
[19]
|
Dayan, F., Roux, D., Brahimi-Horn, M.C., et al. (2006) The Oxygen Sensor Factor-Inhibiting Hypoxia-Inducible Factor-1 Controls Expression of Distinct Genes through the Bifunctional Transcriptional Character of Hypoxia-Inducible Factor-1α. Cancer Research, 66, 3688-3698. https://doi.org/10.1158/0008-5472.CAN-05-4564
|
[20]
|
Semenza, G.L. (2010) Defining the Role of Hypox-ia-Inducible Factor 1 in Cancer Biology and Therapeutics. Oncogene, 29, 625-634. https://doi.org/10.1038/onc.2009.441
|
[21]
|
Tang, S.-W., Chang, W.-H., Su, Y.-C., et al. (2009) MYC Pathway Is Activated in Clear Cell Renal Cell Carcinoma and Essential for Proliferation of Clear Cell Renal Cell Carcinoma Cells. Cancer Letters, 273, 35-43.
https://doi.org/10.1016/j.canlet.2008.07.038
|
[22]
|
Xu, D., Aka, J.A., Wang, R., et al. (2017) 17beta-Hydroxysteroid Dehydrogenase Type 5 Is Negatively Correlated to Apoptosis Inhibitor GRP78 and Tumor-Secreted Protein PGK1, and Modulates Breast Cancer Cell Viability and Proliferation. The Journal of Steroid Biochemistry and Molecular Biology, 171, 270-280.
https://doi.org/10.1016/j.jsbmb.2017.04.009
|
[23]
|
Shaw, J., Utz, P., Durand, D., et al. (1988) Identification of a Putative Regulator of Early T Cell Activation Genes. Science, 241, 202-205. https://doi.org/10.1126/science.3260404
|
[24]
|
Moeller, B.J., Richardson, R.A. and Dewhirst, M.W. (2007) Hypoxia and Radiotherapy: Opportunities for Improved Outcomes in Cancer Treatment. Cancer and Metastasis Reviews, 26, 241-248.
https://doi.org/10.1007/s10555-007-9056-0
|
[25]
|
Ameis, H.M., Drenckhan, A., von Loga, K., et al. (2013) PGK1 as Predictor of CXCR4 Expression, Bone Marrow Metastases and Survival in Neuroblastoma. PLOS ONE, 8, e83701. https://doi.org/10.1371/journal.pone.0083701
|
[26]
|
Zieker, D., Kouml, I., Traub, F., et al. (2008) PGK1 a Potential Marker for Peritoneal Dissemination in Gastric Cancer. Cellular Physiology and Biochemistry, 21, 429-436. https://doi.org/10.1159/000129635
|
[27]
|
Zhang, Y., Yu, G., Chu, H., et al. (2018) Macrophage-Associated PGK1 Phosphorylation Promotes Aerobic Glycolysis and Tumorigenesis. Molecular Cell, 71, 201-215.e7. https://doi.org/10.1016/j.molcel.2018.06.023
|
[28]
|
Qian, X., Li, X., Cai, Q., et al. (2017) Phosphoglycerate Kinase 1 Phosphorylates Beclin1 to Induce Autophagy. Molecular Cell, 65, 917-931.e6. https://doi.org/10.1016/j.molcel.2017.01.027
|
[29]
|
Wang, S., Jiang, B., Zhang, T., et al. (2015) Insulin and mTOR Pathway Regulate HDAC3-Mediated Deacetylation and Activation of PGK1. PLOS Biology, 13, e1002243. https://doi.org/10.1371/journal.pbio.1002243
|
[30]
|
Yu, T., Zhao, Y., Hu, Z., et al. (2017) MetaLnc9 Facilitates Lung Cancer Metastasis via a PGK1-Activated AKT/mTOR Pathway. Cancer Research, 77, 5782-5794. https://doi.org/10.1158/0008-5472.CAN-17-0671
|
[31]
|
Dong, W. and Wu, X. (2018) Overexpression of Rab11-FIP2 in Colorectal Cancer Cells Promotes Tumor Migration and Angiogenesis through Increasing Secretion of PAI-1. Cancer Cell International, 18, 35.
https://doi.org/10.1186/s12935-018-0532-0
|
[32]
|
Xu, C., Wang, J., Xia, X., et al. (2016) Rab11-FIP2 Promotes Colorectal Cancer Migration and Invasion by Regulating PI3K/AKT/MMP7 Signaling Pathway. Biochemical and Bio-physical Research Communications, 470, 397-404.
https://doi.org/10.1016/j.bbrc.2016.01.031
|
[33]
|
Dong, W., Qin, G. and Shen, R. (2016) Rab11-FIP2 Promotes the Metastasis of Gastric Cancer Cells: Rab11-FIP2 Promotes the Metastasis of Gastric Cancer Cells. International Journal of Cancer, 138, 1680-1688.
https://doi.org/10.1002/ijc.29899
|
[34]
|
Dong, W., Li, H. and Wu, X. (2019) Rab11-FIP2 Suppressed Tumor Growth via Regulation of PGK1 Ubiquitination in Non-Small Cell Lung Cancer. Biochemical and Biophysical Research Communications, 508, 60-65.
https://doi.org/10.1016/j.bbrc.2018.11.108
|
[35]
|
Cai, Q., Wang, S., Jin, L., et al. (2019) Long Non-Coding RNA GBCDRlnc1 Induces Chemoresistance of Gallbladder Cancer Cells by Activating Autophagy. Molecular Cancer, 18, 82. https://doi.org/10.1186/s12943-019-1016-0
|
[36]
|
Chu, Z., Huo, N., Zhu, X., et al. (2021) FOXO3A-Induced LINC00926 Suppresses Breast Tumor Growth and Metastasis through Inhibition of PGK1-Mediated Warburg Effect. Molecular Therapy, 29, 2737-2753.
https://doi.org/10.1016/j.ymthe.2021.04.036
|
[37]
|
Liu, S.K., Song, L.L., Yao, H.R. and Zhang, L. (2022) HPV16 E6/E7 Stabilize PGK1 Protein by Reducing Its Poly- Ubiquitination in Cervical Cancer. Cell Biology International, 46, 370-380. https://doi.org/10.1002/cbin.11744
|
[38]
|
Nie, H., Ju, H., Fan, J., et al. (2020) O-GlcNAcylation of PGK1 Coordinates Glycolysis and TCA Cycle to Promote Tumor Growth. Nature Communications, 11, Article No. 36. https://doi.org/10.1038/s41467-019-13601-8
|
[39]
|
张乃文. PGK1及其赖氨酸琥珀酰化修饰在肾细胞癌中的作用及其相关机制研究[D]: [博士学位论文]. 沈阳: 中国医科大学, 2018.
|
[40]
|
Wang, J., Wang, J., Dai, J., et al. (2007) A Glycolytic Mechanism Regulating an Angiogenic Switch in Prostate Cancer. Cancer Research, 67, 149-159. https://doi.org/10.1158/0008-5472.CAN-06-2971
|
[41]
|
Liang, C., Shi, S., Qin, Y., et al. (2020) Localisation of PGK1 Determines Metabolic Phenotype to Balance Metastasis and Proliferation in Patients with SMAD4-Negative Pan-creatic Cancer. Gut, 69, 888-900.
https://doi.org/10.1136/gutjnl-2018-317163
|
[42]
|
Goldstein, M. and Kastan, M.B. (2015) The DNA Damage Re-sponse: Implications for Tumor Responses to Radiation and Chemotherapy. Annual Review of Medicine, 66, 129-143. https://doi.org/10.1146/annurev-med-081313-121208
|
[43]
|
Li, L., Bai, Y., Gao, Y., et al. (2021) Systematic Analy-sis Uncovers Associations of PGK1 with Prognosis and Immunological Characteristics in Breast Cancer. Disease Mark-ers, 2021, Article ID: 7711151.
https://doi.org/10.1155/2021/7711151
|
[44]
|
Wang, J., Ying, G., Wang, J., et al. (2010) Characterization of Phos-phoglycerate Kinase-1 Expression of Stromal Cells Derived from Tumor Microenvironment in Prostate Cancer Progres-sion. Cancer Research, 70, 471-480.
https://doi.org/10.1158/0008-5472.CAN-09-2863
|
[45]
|
Shichijo, S., Azuma, K., Komatsu, N., et al. (2004) Two Proliferation-Related Proteins, TYMS and PGK1, Could Be New Cytotoxic T Lymphocyte-Directed Tumor-Associated Antigens of HLA-A2+ Colon Cancer. Clinical Cancer Research, 10, 5828-5836. https://doi.org/10.1158/1078-0432.CCR-04-0350
|